Volatile drug use and overdose during the first year of the COVID-19 pandemic in the United States
Description
CONCLUSIONS: Volatile drug use during the COVID-19 pandemic was common, appeared to be driven by structural vulnerability, and was associated with increased overdose risk. Addressing volatile drug use through interventions that ensure structural
